Head and neck squamous cell carcinoma is the sixth leading cancer worldwide by incidence. Head and neck squamous cell carcinoma progresses from the mucosal membrane, comprising the paranasal sinuses and nasal cavity, the nasopharynx, the hypopharynx, larynx, and trachea, and the oropharynx and oral cavity. According to WHO, The annual incidence of head and neck squamous cell carcinoma worldwide is more than 550,000 cases with around 300,000 deaths every year. Alcohol and tobacco is the risk factor for head and neck squamous cell carcinoma. Five years survival rate of patients with head and neck squamous cell carcinoma is about 40-50%.
This report contains market size and forecasts of Head And Neck Squamous Cell Carcinoma Treatment in Global, including the following market information:
Global Head And Neck Squamous Cell Carcinoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Head And Neck Squamous Cell Carcinoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Head And Neck Squamous Cell Carcinoma Treatment include Amgen, AbbVie, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, GlaxoSmithKline, Teva, Roche and Celgene. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Head And Neck Squamous Cell Carcinoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Head And Neck Squamous Cell Carcinoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Head And Neck Squamous Cell Carcinoma Treatment Market Segment Percentages, by Type, 2021 (%)
Surgical Therapy
Radiation Therapy
Drug Treatment
Global Head And Neck Squamous Cell Carcinoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Head And Neck Squamous Cell Carcinoma Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Global Head And Neck Squamous Cell Carcinoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Head And Neck Squamous Cell Carcinoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Head And Neck Squamous Cell Carcinoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Head And Neck Squamous Cell Carcinoma Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AbbVie
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
GlaxoSmithKline
Teva
Roche
Celgene